The aim of this study is to determine the risk factors for development of ventilator-associated pneumonia (VAP) and to identify the prognostic factors of VAP among Coronavirus Disease 2019 (CoViD-19) patients. We hypothesized that CoViD-19 serves as a high risk factor for the development of VAP and it affects clinical outcome measures negatively.
Coronavirus Disease 2019 (CoViD-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) became a pandemic affecting thousands of individuals worldwide. A considerable proportion of CoViD-19 patients require admission to the intensive care unit (ICU), although limited data are available on their clinical characteristics and course. The results of retrospective studies indicate older age, presence of comorbidies and secondary infections as predictors of mortality among this population. Further evaluation regarding ICU clinical course and predictors of mortality is needed. The aim of this study is to determine the risk factors for development of VAP and to identify the prognostic factors of VAP among CoViD-19 patients.
Study Type
OBSERVATIONAL
Enrollment
30
Diagnosis of ventilator-associated pneumonia is based upon the routine daily clinical and laboratory parameters.
Semmelweis University
Budapest, Hungary
RECRUITING28-day all-cause mortality
Time frame: at study completion, anticipated 5 months
Days of mechanical ventilation
Time frame: average time frame expected 2-3 weeks
ICU length-of-stay
Time frame: average time frame expected 3-4 weeks
Antibiotic utilization
Time frame: average time frame expected 3-4 weeks (at discharge from ICU)
Ventilator-associated pneumonia rate
Time frame: at study completion, anticipated 5 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.